Related Experiment Video
Updated: Apr 9, 2026

Separating Bacteria by Capsule Amount Using a Discontinuous Density Gradient
Published on: January 7, 2019
Regulation of capsule in Neisseria meningitidis
Yih-Ling Tzeng1, Jennifer Thomas1, David S Stephens1
1a Department of Medicine , Emory University School of Medicine, Woodruff Health Sciences Center , Atlanta , GA , USA.
Abstract:
Neisseria meningitidis, a devastating pathogen exclusive to humans, expresses capsular polysaccharides that are the major meningococcal virulence determinants and the basis for successful meningococcal vaccines. With rare exceptions, the expression of capsule (serogroups A, B, C, W, X, Y) is required for systemic invasive meningococcal disease. Changes in capsule expression or structure (e.g. hypo- or hyper-encapsulation, capsule "switching", acetylation) can influence immunologic diagnostic assays or lead to immune escape. The loss or down-regulation of capsule is also critical in meningococcal biology facilitating meningococcal attachment, microcolony formation and the carriage state at human mucosal surfaces. Encapsulated meningococci contain a cps locus with promoters located in an intergenic region between the biosynthesis and the conserved capsule transport operons. The cps intergenic region is transcriptionally regulated (and thus the amount of capsule expressed) by IS element insertion, by a two-component system, MisR/MisS and through sequence changes that result in post-transcriptional RNA thermoregulation. Reversible on-off phase variation of capsule expression is controlled by slipped strand mispairing of homo-polymeric tracts and by precise insertion and excision of IS elements (e.g. IS1301) in the biosynthesis operon. Capsule structure can be altered by phase-variable expression of capsular polymer modification enzymes or "switched" through transformation and homologous recombination of different polymerases. Understanding the complex regulation of meningococcal capsule has important implications for meningococcal biology, pathogenesis, diagnostics, current and future vaccine development and vaccine strategies.
Insights
Neisseria meningitidis capsule expression is crucial for disease and carriage. Its complex regulation impacts virulence, immune evasion, and vaccine development strategies.
Area of Science:
- Microbiology
- Molecular Biology
- Immunology
Background:
- Neisseria meningitidis capsule is a key virulence factor and vaccine target.
- Capsule expression is essential for invasive disease but lost during carriage.
Purpose of the Study:
- To elucidate the complex regulatory mechanisms governing Neisseria meningitidis capsule expression.
- To understand how capsule regulation influences pathogenesis, diagnostics, and vaccine strategies.
Main Methods:
- Analysis of the cps locus and its regulatory elements.
- Investigating transcriptional regulation via IS elements, two-component systems (MisR/MisS), and RNA thermoregulation.
- Examining mechanisms of phase variation and capsule switching.
Main Results:
- Capsule expression is tightly controlled at transcriptional and post-transcriptional levels.
- Phase variation and capsule switching are mediated by genetic elements and recombination.
- Regulatory mechanisms allow adaptation for virulence, immune escape, and carriage.
Conclusions:
- Understanding meningococcal capsule regulation is vital for controlling invasive disease.
- Knowledge of these mechanisms informs the development of novel diagnostics and vaccines.
- Targeting capsule regulation could offer new therapeutic and preventative strategies.
Related Concept Videos
Regulation of Bacterial Virulence
Outer Layers of the Cell Envelope
Global Regulatory Systems
Inhibitors of Gram-positive Cell Wall Synthesis
Mechanism of Antibiotic Resistance in MRSA
Gene Regulation During Sporulation

